Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone in Controlled Ovarian Hyperstimulation
NCT03966339Unknown
- Sponsor
- Reproductive and Genetic Hospital of CITIC-Xiangya
- Start
- Aug 2019
- Primary completion
- Dec 2022
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of somatropin in female infertility, sponsored by Reproductive and Genetic Hospital of CITIC-Xiangya. Primary endpoints: Number of high-quality embryos at D3 at 3 days and Proportion of high-quality embryos at D3 at 3 days. Status: unknown.
02
Drugs
somatropin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03966339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03966339.